Impact of depression on long-term outcome after renal transplantation: A prospective cohort study

Transplantation

Volumn 94, Issue 10, 2012, Pages 1033-1040

  Zelle, Dorien M ^a   Dorland, Heleen F ^a   Rosmalen, Judith G M ^a   Corpeleijn, Eva ^a   Gans, Reinold O B ^a   Homan Van Der Heide, Jaap J ^a   Van Son, Willem J ^a   Navis, Gerjan ^a   Bakker, Stephan J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

All cause mortality; Cardiovascular mortality; Depression; Graft failure

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISOLONE; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIALYSIS; DRUG BLOOD LEVEL; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SYMPTOM CHECKLIST 90; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEPRESSION; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84870240114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31826bc3c8     Document Type: Article

References (51)

1. Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int 2004; 65: 1937.
2. Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35: 629.
3. Rocha G, Poli de Figueiredo CE, d'Avila D, et al. Depressive symptoms and kidney transplant outcome. Transplant Proc 2001; 33: 3424.
4. Akman B, Ozdemir FN, Sezer S, et al. Depression levels before and after renal transplantation. Transplant Proc 2004; 36: 111.
5. Herrmann C, Brand-Driehorst S, Buss U, et al. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res 2000; 48: 455.
6. Barefoot JC, Brummett BH, Helms MJ, et al. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000; 62: 790.
7. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 88: 337.
8. Bruce DG, Davis WA, Starkstein SE, et al. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2005; 48: 2532.
9. Whooley MA, de JP, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379.
10. Chilcot J, Wellsted D, Da Silva-Gane M, et al. Depression on dialysis. Nephron Clin Pract 2008; 108: c256.
11. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000; 57: 2093.
12. Cukor D, Rosenthal DS, Jindal RM, et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int 2009; 75: 1223.
13. Dobbels F, Skeans MA, Snyder JJ, et al. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008; 51: 819.
14. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527.
15. Moons P, De GS, Versteven K, et al. Psychometric properties of the "Modified Transplant Symptom Occurrence and Symptom Distress Scale". J Nurs Meas 2001; 9: 115.
16. Moons P, Vanrenterghem Y, Van Hooff JP, et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. Transpl Int 2003; 16: 653.
17. Pascazio L, Nardone IB, Clarici A, et al. Anxiety, depression and emotional profile in renal transplant recipients and healthy subjects: a comparative study. Transplant Proc 2010; 42: 3586.
18. Zelle DM, Corpeleijn E, Stolk RP, et al. Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011; 6: 898.
19. Remport A, Keszei A, Vamos EP, et al. Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study. Int Urol Nephrol 2011; 43: 215.
20. Patten SB. Exogenous corticosteroids and major depression in the general population. J Psychosom Res 2000; 49: 447.
21. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 1999; 83: 495.
22. Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states. Psychosom Med 2003; 65: 665.
23. Christmas DM, Potokar J, Davies SJ. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat 2011; 7: 431.
24. Pawlak K, Mysliwiec M, Pawlak D. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients. Thromb Res 2010; 125: e40.
25. Noohi S, Khaghani-Zadeh M, Javadipour M, et al. Anxiety and depression are correlated with higher morbidity after kidney transplantation. Transplant Proc 2007; 39: 1074.
26. van Ree RM, Oterdoom LH, de Vries AP, et al. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. Transplantation 2008; 86: 1713.
27. Murphy EL, Murtagh FE, Carey I, et al. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract 2009; 111: c74.
28. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648.
29. Descamps-Latscha B, Herbelin A, Nguyen AT, et al. Dysregulation of the immune system in chronic uremic and hemodialysed patients. Presse Med 1995; 24: 405.
30. Gris JC, Branger B, Vecina F, et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807.
31. Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311.
32. Jones H, Talwar M, Nogueira JM, et al. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis. Transplantation 2012; 93: 923.
33. Agarwal PK, Hellemons ME, Zelle DM, et al. Smoking is a risk factor for graft failure and mortality after renal transplantation. Am J Nephrol 2011; 34: 26.
34. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011; 306: 1241.
35. de JP, Rosmalen JG, Kema IP, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci Biobehav Rev 2010; 35: 84.
36. Zelle DM, Agarwal PK, Ramirez JL, et al. Alcohol consumption, new onset of diabetes after transplantation, and all-cause mortality in renal transplant recipients. Transplantation 2011; 92: 203.
37. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101.
38. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14: 88.
39. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994; 8: 550.
40. Joseph JT, Baines LS, Morris MC, et al. Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis 2003; 42: 431.
41. Cukor D, Newville H, Jindal R. Depression and immunosuppressive medication adherence in kidney transplant patients. Gen Hosp Psychiatry 2008; 30: 386.
42. Aben I, Verhey F, Lousberg R, et al. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 2002; 43: 386.
43. Zelle DM, Corpeleijn E, van Ree RM, et al. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. Am J Transplant 2010; 10: 106.
44. Sinkeler SJ, Zelle DM, Homan van der Heide JJ, et al. Endogenous plasma erythropoietin, cardiovascular mortality and all-cause mortality in renal transplant recipients. Am J Transplant 2011; 12: 485.
45. Beljouw IMJvan, Verhaak PFM, NIVEL. Geschikte uitkomstmaten voor routinematige registratie door eerstelijns psychologen. 2010.
46. Stant AD, Ten Vergert EM, den Boer PC, et al. Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders. Acta Psychiatr Scand 2008; 117: 57.
47. Bruce DS, Newell KA, Josephson MA, et al. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation 1996; 62: 451.
48. Bernstein IH, Wendt B, Nasr SJ, et al. Screening for major depression in private practice. J Psychiatr Pract 2009; 15: 87.
49. Koeter MW. Validity of the GHQ and SCL anxiety and depression scales: a comparative study. J Affect Disord 1992; 24: 271.
50. Arrindell WA, Ettema JHM. Dimensional structure, reliability and validity of the Dutch version of the Symptom Checklist (SCL-90): Data based on a phobic and a "normal" population. Ned Tijdschr Psychol 1981; 36: 77.
51. Oterdoom LH, Gansevoort RT, Schouten JP, et al. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 2009; 207: 534.